Synthesis and SAR of 5,6-Diarylpyridines as Human CB1 Inverse Agonists.

Synthesis and Activity of 4,5-Diarylimid

Synthesis and Activity of 4,5-Diarylimidazoles as Human CB1 Receptor Inverse Agonists.

✍ Christopher W. Plummer; et al. et al. 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 11 KB 👁 1 views

Synthesis of Functionalized 1,8-Naphthyr

Synthesis of Functionalized 1,8-Naphthyridinones and Their Evaluation as Novel, Orally Active CB1 Receptor Inverse Agonists.

✍ John S. Debenham; et al. et al. 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 22 KB 👁 1 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.

ChemInform Abstract: Discovery of Benzhy

ChemInform Abstract: Discovery of Benzhydrylpiperazine Derivatives as CB1 Receptor Inverse Agonists via Privileged Structure-Based Approach.

✍ Tao Meng; Jue Wang; Hongli Peng; Guanghua Fang; Min Li; Bing Xiong; Xin Xie; Yon 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 17 KB 👁 1 views

Synthesis and SAR Studies of 3-Phenoxypr

Synthesis and SAR Studies of 3-Phenoxypropyl Piperidine Analogues as ORL1 (NOP) Receptor Agonists.

✍ Ronald Palin; et al. et al. 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 21 KB 👁 2 views

ChemInform Abstract: Synthesis, SAR and

ChemInform Abstract: Synthesis, SAR and Intramolecular Hydrogen Bonding Pattern of 1,3,5-Trisubstituted 4,5-Dihydropyrazoles as Potent Cannabinoid CB1 Receptor Antagonists.

✍ Jos H. M. Lange; Martina A. W. van der Neut; Arnold P. den Hartog; Henri C. Wals 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 36 KB 👁 2 views

2-Arylimino-5,6-dihydro-4H-1,3-thiazines

2-Arylimino-5,6-dihydro-4H-1,3-thiazines as a New Class of Cannabinoid Receptor Agonists. Part 1. Discovery of CB2 Receptor Selective Compounds.

✍ Hiroyuki Kai; et al. et al. 📂 Article 📅 2007 🏛 John Wiley and Sons ⚖ 19 KB 👁 1 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.